600380 Joincare Pharmaceutical Group Industry
- 11.68
- 0.000.00%
Joincare Pharmaceutical Group Industry News
Health Yuan Pharmaceutical Group Co., Ltd. 2023 CEO Work Report
Special report by the board of directors of Health Yuan Pharmaceutical Group Co., Ltd. on the independence of the company\'s independent directors
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the launch of foreign exchange derivatives trading business
Health Yuan Pharmaceutical Group Co., Ltd. 2023 Risk Management and Internal Control Evaluation Report
Health Yuan Pharmaceutical Group Co., Ltd. Board Audit Committee Performance Report 2023
Report of the Audit Committee of the Board of Directors of Health Yuan Pharmaceutical Group Co., Ltd. on the performance of supervisory duties by the 2023 annual audit accounting firm
Health Yuan Pharmaceutical Group Co., Ltd. 2024 “Improve Quality, Increase Efficiency and Value Return” Action Plan
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on changing supervisors and nominating candidates for supervisors
Notice of Health Yuan Pharmaceutical Group Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Meeting materials of the 2024 Second Extraordinary General Meeting of Shareholders of Health Yuan Pharmaceutical Group Co., Ltd.
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the launch of futures hedging business
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on the extension of some fund-raising investment projects
Announcement of Jiaozuo Health Yuan Pharmaceutical Group Co., Ltd. on the daily related transactions between the holding subsidiary Jiaozuo Health Yuan and Jinguan Electric Power
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on obtaining a clinical approval notice
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on approval for clinical trials of simeglutide injection
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. regarding the signing of a loan agreement between the Company and the international financial company International Finance Corporation
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Health Yuan Pharmaceutical Group Co., Ltd.
Legal Opinion of Beijing Deheng (Shenzhen) Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Health Yuan Pharmaceutical Group Co., Ltd.
Announcement of Health Yuan Pharmaceutical Group Co., Ltd. on obtaining a clinical trial approval notice
Prompt announcement of Health Yuan Pharmaceutical Group Co., Ltd. on convening the 2024 First Extraordinary General Meeting of Shareholders
Analysis
Price Target
No Data
